This content was published on Oct 24, 2024 On Thursday, the Swiss Federal Railways presented its first fully renovated InterCity tilting train (ICN). Read more: Swiss railways presents first fully ...
Last week, GlaxoSmithKline and Northwestern University filed separate lawsuits against Moderna, accusing its mRNA-based vaccines of ...
Despite strong cash flow and organic growth in most of its key brands, high leverage and mixed valuation ratios lead to a ...
The allergy treatment market is set to experience robust growth, with an estimated valuation of US$ 20.20 billion in 2022 and ...
Hosted on MSN22h
GSK’s Arexvy Vaccine Shows Promise for Broader UseGlaxoSmithKline (GB:GSK) has released an update. GSK has announced promising new data for its RSV vaccine, Arexvy, which ...
The projected market expansion presents a unique opportunity for stakeholders to invest in and prioritize the development of ...
North Carolina is a leading place for biotech, and a big part of that success comes from GlaxoSmithKline (GSK). This global ...
Dr. Ernest Mario, the founding chair of the Duke University Health System Board of Directors and a leader in the ...
A persistent, often progressive, lung disease, COPD results from chronic inflammation that leads to structural changes ...
Dr. Ernest Mario, the founding chair of the Duke University Health System Board of Directors and a leader in the ...
UBS analyst Jo Walton maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of p1,580.00. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback